Loading clinical trials...
Loading clinical trials...
A Phase I Study of Sorafenib (Nexavar®) in Combination With FOLFIRI as First Line Therapy for Metastatic Colorectal Cancer
Conditions
Interventions
sorafenib + FOLFIRI
Locations
1
Canada
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
Start Date
October 1, 2008
Primary Completion Date
May 1, 2011
Completion Date
December 1, 2012
Last Updated
May 13, 2013
NCT06625775
NCT04657068
NCT06607458
NCT06820463
NCT07361003
NCT06792695
Lead Sponsor
Ottawa Hospital Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions